<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01974609</url>
  </required_header>
  <id_info>
    <org_study_id>Narcotic vs. Non-narcotic Pain</org_study_id>
    <nct_id>NCT01974609</nct_id>
  </id_info>
  <brief_title>Narcotic vs. Non-narcotic Pain Study Protocol</brief_title>
  <official_title>A Randomized, Controlled Trial Comparing Combination Therapy of Ibuprofen + Acetaminophen Versus Hydrocodone + Acetaminophen for the Treatment of Pain After Carpal Tunnel Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Horizon Health Network</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Lawson Health Research Institute</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Michigan</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Jefferson Medical College of Thomas Jefferson University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>McGill University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Western Ontario, Canada</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Sanford Health</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Carilion Clinic</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Horizon Health Network</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purposes of this noninferiority randomized clinical trial are to:

        1. determine whether the most commonly used commonly used non-narcotic analgesic (ibuprofen
           600 mg + acetaminophen 325 mg) provides pain relief that is not unacceptably worse than
           the most commonly prescribed narcotic containing analgesic (hydrocodone 5 mg. +
           acetaminophen 325 mg, equivalent to Norco 5/325) in patients undergoing carpal tunnel
           release.

        2. Determine whether the following covariates affect pain level following surgery or
           medication usage: gender, country (US/Canada), pre-operative CTS symptoms, site, workers
           compensation status and employment status (employed/self-employed/unemployed-able to
           work/unemployed-unable to work)
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Participants will be provided with forms by site coordinators and will be provided in person
      instruction on how to fill out the pain intensity scores, the pain interference scores, the
      pain medication diary, and the final pain relief assessment form.

      Medications will be identified only by number and will be available to the participant after
      standard instruction on use of medications is provided by the surgeon or research associate.
      Patients will be instructed - verbally and written - to take the study medication (2 capsules
      per dose) up to four times per day as needed for pain for 1 week or until pain free.

      If patients experience intolerable discomfort, they will be able to contact personnel (24
      hours on call) associated with the study to receive an alternate analgesic. The surgeon will
      determine if the patient is taking the maximum dose and then prescribe additional study drug
      or a non-study drug as an alternative. If the patient receives pain medication outside of the
      study protocol, the medication will be recorded, this will be recorded as a protocol
      violation. If this occurs in more than 20 people during the trial a per-protocol and efficacy
      analysis will be considered.

      Participants will return to see the surgeon or designate between post-operative day 7 and 14
      to return their diary, unused medication, and post-operative pain satisfaction survey.
      Participants will be specifically asked about: any adverse events, compliance with the
      program and the reason for any deviation and any other analgesic medication taken during the
      course of the study.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2016</start_date>
  <completion_date type="Anticipated">March 2019</completion_date>
  <primary_completion_date type="Anticipated">March 2019</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain relief</measure>
    <time_frame>7-15 days</time_frame>
    <description>1. Determine whether the most commonly used nonnarcotic analgesics (ibuprofen 600 mg + acetaminophen 325 mg) provide pain relief that is not unacceptably worse than the most commonly prescribed narcotic containing analgesic (hydrocodone 5 mg + acetaminophen 325 mg, equivalent to NorcoÂ® 5/325) in patients undergoing carpal tunnel release.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">400</enrollment>
  <condition>Carpal Tunnel</condition>
  <arm_group>
    <arm_group_label>Narcotic</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Hydrocodone + acetaminophen 4 times per day 1 week after surgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>non-narcotic</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>ibuprofen + acetaminophen 4 times per day 1 week after surgery</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Narcotic</intervention_name>
    <description>Hydrocodone 5mg + acetaminophen 325 mg</description>
    <arm_group_label>Narcotic</arm_group_label>
    <other_name>Hydrocodone/acetaminophen</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>non-narcotic</intervention_name>
    <description>ibuprofen 600mg + acetaminophen 325 mg</description>
    <arm_group_label>non-narcotic</arm_group_label>
    <other_name>ibuprofen + acetaminophen</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All patients undergoing elective a primary carpal tunnel release will be considered
             eligible

        Exclusion Criteria:

          -  Patients wil be excluded for any of the following:

          -  previously enrolled in this study (for carpal tunnel surgery on the other hand);

          -  history of chronic opioid use;

          -  documented or suspected substance abuse;

          -  individuals currently on daily use of ibuprofen, acetaminophen or other pain altering
             medication including medications like Neurontin (gabapentin) and Ultram (tramadol)

          -  individuals with documented or suspected chronic pain syndrome;

          -  reported allergy or adverse reaction to hydrocodone, acetaminophen, or ibuprofen;

          -  those with a history or symptoms of any significant medical problem in the last year
             (i.e., arrhythmia, impaired cardiovascular function, gastrointestinal bleeding, liver
             disease, renal disease);

          -  patients with active peptic ulcer disease (history of severe heartburn);

          -  symptoms of infection with initial enrollment;

          -  pregnant or lactating women;

          -  those with a diagnosis of cognitive impairment;

          -  patients unable or unwilling to provide informed consent for surgery or enrollment in
             a clinical trial;

          -  patients unable or unwilling to fill out the forms or understand the consent form

          -  prior carpal tunnel surgery on the hand to be operated on

          -  individuals currently taking Coumadin, Plavix, or medications that increase bleeding;
             or

          -  patients with other medical or psychological health conditions that preclude then from
             receiving either intervention or returning for follow-up visits
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Donald Lalonde, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Saint John, NB</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Donald Lalonde, MD</last_name>
    <phone>506-648-7950</phone>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Joy MacDermid, PhD</last_name>
    <phone>519-646-6100</phone>
    <phone_ext>64636</phone_ext>
  </overall_contact_backup>
  <location>
    <facility>
      <name>The Philadelphia Hand Center</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19107</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Patrick Kane, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sanford orthopedics and Sports Medicine-Sioux Falls</name>
      <address>
        <city>Sioux Falls</city>
        <state>South Dakota</state>
        <zip>57104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Robert Van Demark, MD</last_name>
      <phone>605-328-1368</phone>
      <email>Robert.VanDemarkJr@SanfordHealth.org</email>
    </contact>
    <contact_backup>
      <last_name>Angela Van Veldhuizen</last_name>
      <phone>605-328-1368</phone>
      <email>Angela.Vanveldhuizen@SanfordHealth.org</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>CarilionClinic</name>
      <address>
        <city>Roanoke</city>
        <state>Virginia</state>
        <zip>24014</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cassandra Mierisch, MD</last_name>
      <phone>540-588-8076</phone>
      <email>crmierisch@carilionclinic.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Horizon Health Network</name>
      <address>
        <city>Saint John</city>
        <state>New Brunswick</state>
        <zip>E2L 4L4</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Donald Lalonde</last_name>
      <email>dlalonde@drlalonde.ca</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Lawson Health Research Institute</name>
      <address>
        <city>London</city>
        <state>Ontario</state>
        <zip>N6A 4V2</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Joy MacDermid, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Western Ontario, Canada</name>
      <address>
        <city>London</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bing Gan</last_name>
      <email>bsgan@rogers.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>McGill University</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>H3A 0G4</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mario Luc</last_name>
      <email>mario.luc@mcgill.ca</email>
    </contact>
    <investigator>
      <last_name>Mario Luc, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 28, 2013</study_first_submitted>
  <study_first_submitted_qc>October 31, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 1, 2013</study_first_posted>
  <last_update_submitted>August 30, 2017</last_update_submitted>
  <last_update_submitted_qc>August 30, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 31, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Horizon Health Network</investigator_affiliation>
    <investigator_full_name>Don Lalonde MD</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>pain relief</keyword>
  <keyword>narcotic pain relief</keyword>
  <keyword>non-narcotic pain relief</keyword>
  <keyword>post-operative pain relief</keyword>
  <keyword>carpal tunnel</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Carpal Tunnel Syndrome</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acetaminophen</mesh_term>
    <mesh_term>Ibuprofen</mesh_term>
    <mesh_term>Acetaminophen, hydrocodone drug combination</mesh_term>
    <mesh_term>Hydrocodone</mesh_term>
    <mesh_term>Narcotics</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

